 |  |  | | | | | | Our Big Five-0 Achievements |  | |
| | |
 | Ensuring more children survive leukaemia |
In 1960, when the charity was formed, children with leukaemia had almost no hope of survival. Now, thanks to research funded by Leukaemia & Lymphoma Research more than 9 out of 10 children survive the most common form of leukaemia.
| Improving diagnosis so everyone gets the treatment they need quickly |
In 1960 it was thought that there were only four types of blood cancers: leukaemia, Hodgkin's and non-Hodgkin's lymphoma, and myeloma. Our dedicated researchers have revealed that there are many subsets of these diseases – each requiring different treatment. This information has allowed our scientists to develop tests so that patients all over the world receive the treatment they need.
| Developing better, safer treatments tailored to each patient |
50 years ago treatments were very primitive and extremely toxic for patients. Even if patients responded, any improvement was short lived. Leukaemia & Lymphoma Research has invested in clinical trials to find more effective drugs for patients with leukaemia, lymphoma and myeloma resulting in greatly improved treatments – and these diseases can now be managed much more effectively and more patients than ever before are saved.
| Investing in research that swiftly benefits patients |
Leukaemia & Lymphoma Research invests in specialist centres where scientists work alongside doctors. This means research benefits are swiftly translated into improved patient care so that more lives are saved.
| Learning how to prevent all blood cancers so families are spared the pain of losing a loved one |
Survival rates have increased dramatically over the last 50 years thanks to continued investment by Leukaemia & Lymphoma Research in world-class research. But despite advances, people are still losing loved ones to leukaemia, lymphoma and myeloma.
| |
| |
